ArticleNature communications2026
SARS-CoV-2 infection during the first trimester leads to profound immune dysregulation at the maternal-fetal interface despite limited virus detection in placental tissues.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
Abstract
The endemic nature of SARS-CoV-2 underscores the imperative to elucidate its effects on pregnancy, particularly the potential for vertical transmission and its influence on the early maternal-fetal interface. Here, we performed an extensive cohort study involving 761 pregnant women who voluntarily terminated their pregnancies during the first trimester. Analyses conducted using RT‒qPCR, fluorescence in situ hybridisation, and indirect immunofluorescence showed low detection levels of SARS-CoV-2 infection within villous and decidual tissues. Single-cell RNA sequencing analysis revealed an absence of cell populations demonstrating significant coexpression of ACE2 and TMPRSS2, potentially providing a mechanistic explanation for the rare incidence of viral infection within placental tissues. The maternal systemic inflammatory response was activated, and the levels of IL-31, IL-5, and GRO-α were significantly elevated during acute infection. Furthermore, increased IgG titres were negatively correlated with TNF-β concentrations, suggesting a protective immunomodulatory function of IgG antibodies. Conversely, both bulk and single-cell transcriptomic analyses revealed pronounced, cell type-specific antiviral and immune responses within the placental microenvironment. A pervasive interferon-stimulated gene signature was identified, accompanied by the emergence of M2-like macrophages with diminished antigen presentation capacity during convalescence. Importantly, maternal SARS-CoV-2 infection disrupted intercellular communication networks, notably impairing the activity of the WNT and TGF-β signalling pathways in trophoblasts, thereby altering their differentiation trajectories. In summary, within this large cohort of first-trimester samples, we identified infrequent instances of SARS-CoV-2 infection in both villous and decidual tissues. Nonetheless, infection substantially perturbed the placental immune milieu and trophoblast dynamics, which may adversely affect pregnancy outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.